Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on May 3, 2004

Hypertension. 2004
Published online before print May 3, 2004, doi: 10.1161/01.HYP.0000128022.24598.4f
A more recent version of this article appeared on June 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/6/1258    most recent
01.HYP.0000128022.24598.4fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hiyoshi, H.
Right arrow Articles by Okamoto, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hiyoshi, H.
Right arrow Articles by Okamoto, H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LOSARTAN POTASSIUM
*NITRIC OXIDE
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Gene expression
Right arrow Receptor pharmacology
Right arrow Endothelium/vascular type/nitric oxide

Submitted on February 26, 2004
Revised on March 15, 2004

Stimulation of Cyclic GMP Production via AT2 and B2 Receptors in the Pressure-Overloaded Aorta After Banding

Hiromi Hiyoshi; Katsutoshi Yayama; Masaoki Takano; and Hiroshi Okamoto*

From the Department of Pharmacology, Faculty of Pharmaceutical Sciences and High Technology, Research Center, Kobe Gakuin University, Japan.

* To whom correspondence should be addressed. E-mail: p-okamoto{at}kobegakuin.ac.jp.

Abstract--Abdominal aortic banding induces upregulation of the angiotensin II (Ang II) type-2 (AT2) receptor, thereby decreasing the contractile response to Ang II in the thoracic aorta of the rat. The aim of this study was to use a mouse model to clarify the mechanisms by which the banding elicits upregulation of the aortic AT2 receptor and the subsequent attenuation of Ang II responsiveness. Concomitantly with the elevation in blood pressure and plasma renin concentration after banding, AT2-receptor mRNA levels in the thoracic aorta rapidly increased in mice within 4 days. Upregulation of the AT2 receptor, as well as blood pressure elevation after banding, was abolished by losartan administration. The contractile response to Ang II was depressed in aortic rings of banding mice but not of sham mice, and was restored by either the AT2-receptor antagonist PD123319 or the bradykinin B2-receptor antagonist icatibant. cGMP content in the thoracic aorta of banding mice was 9-fold greater than that of sham mice, and the elevation was reduced to sham levels 1 hour after intravenous injection of PD123319 or icatibant. When aortic rings were incubated with Ang II, cGMP content increased in banding rings but not in sham rings; the pretreatment with PD123319 or icatibant inhibited Ang II-induced cGMP production. These results suggest that aortic banding induces upregulation of the AT2 receptor through increased circulating Ang II via the AT1 receptor, thereby activating a vasodilatory pathway in vessels through the AT2 receptor via the kinin/cGMP system.


Key words: receptors, angiotensin II • bradykinin • nitric oxide • cyclic GMP • vasodilation




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation
Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Yayama, H. Hiyoshi, D. Imazu, and H. Okamoto
Angiotensin II Stimulates Endothelial NO Synthase Phosphorylation in Thoracic Aorta of Mice With Abdominal Aortic Banding Via Type 2 Receptor
Hypertension, November 1, 2006; 48(5): 958 - 964.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. M. Carey and J. Park
Role of Angiotensin Type 2 Receptors in Vasodilation of Resistance and Capacitance Vessels
Hypertension, November 1, 2006; 48(5): 824 - 825.
[Full Text] [PDF]


Home page
HypertensionHome page
R. M. Carey
Cardiovascular and Renal Regulation by the Angiotensin Type 2 Receptor: The AT2 Receptor Comes of Age
Hypertension, May 1, 2005; 45(5): 840 - 844.
[Full Text] [PDF]


Home page
HypertensionHome page
H. Hiyoshi, K. Yayama, M. Takano, and H. Okamoto
Angiotensin Type 2 Receptor-Mediated Phosphorylation of eNOS in the Aortas of Mice With 2-Kidney, 1-Clip Hypertension
Hypertension, May 1, 2005; 45(5): 967 - 973.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
B. T. Andresen, K. Shome, E. K. Jackson, and G. G. Romero
AT2 receptors cross talk with AT1 receptors through a nitric oxide- and RhoA-dependent mechanism resulting in decreased phospholipase D activity
Am J Physiol Renal Physiol, April 1, 2005; 288(4): F763 - F770.
[Abstract] [Full Text] [PDF]